pyridine has been researched along with Experimental Neoplasms in 8 studies
azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pharmacokinetic experiments show oral bioavailability through gastric absorption." | 1.48 | Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization. ( Cescon, DW; Hansen, MD; Hoj, JP; Siddiqui-Jain, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y | 1 |
| Pi, R | 1 |
| Niu, L | 1 |
| Zhao, Y | 1 |
| Ni, D | 1 |
| Song, L | 1 |
| Li, Z | 2 |
| Han, W | 1 |
| Wei, Q | 1 |
| Han, Y | 1 |
| Zhu, T | 1 |
| Luo, Z | 1 |
| Sun, D | 1 |
| Dong, S | 1 |
| Liu, S | 1 |
| Franich, AA | 1 |
| Živković, MD | 1 |
| Ilić-Tomić, T | 1 |
| Đorđević, IS | 1 |
| Nikodinović-Runić, J | 1 |
| Pavić, A | 1 |
| Janjić, GV | 1 |
| Rajković, S | 1 |
| Xu, X | 1 |
| Du, Q | 1 |
| Meng, Y | 1 |
| Wu, H | 1 |
| Li, Y | 1 |
| Zhao, Z | 1 |
| Ge, R | 1 |
| Lu, X | 1 |
| Xue, S | 1 |
| Chen, X | 1 |
| Yang, Y | 1 |
| Wang, J | 1 |
| Bian, J | 1 |
| Siddiqui-Jain, A | 1 |
| Hoj, JP | 1 |
| Cescon, DW | 1 |
| Hansen, MD | 1 |
| Xu, F | 1 |
| Li, W | 1 |
| Shuai, W | 1 |
| Yang, L | 1 |
| Bi, Y | 1 |
| Ma, C | 1 |
| Yao, H | 1 |
| Xu, S | 1 |
| Zhu, Z | 1 |
| Xu, J | 1 |
| Liu, JY | 1 |
| Li, J | 1 |
| Yuan, X | 1 |
| Wang, WM | 1 |
| Xue, JP | 1 |
| Al-Ghorbani, M | 1 |
| Thirusangu, P | 1 |
| Gurupadaswamy, HD | 1 |
| Girish, V | 1 |
| Shamanth Neralagundi, HG | 1 |
| Prabhakar, BT | 1 |
| Khanum, SA | 1 |
| BECK, EG | 1 |
| SANTER, A | 1 |
| BROCKHAUS, A | 1 |
8 other studies available for pyridine and Experimental Neoplasms
| Article | Year |
|---|---|
Novel 2-phenyl-3-(Pyridin-2-yl) thiazolidin-4-one derivatives as potent inhibitors for proliferation of osteosarcoma cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; | 2022 |
New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proli | 2020 |
Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Blood-Brain Barrier; Cell Proliferati | 2020 |
Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
Topics: Amides; Animals; Cell Line, Tumor; Cell Proliferation; Dogs; Dose-Response Relationship, Drug; Human | 2018 |
Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chalcone; Dose-Resp | 2019 |
In vitro photodynamic activities of zinc(II) phthalocyanines substituted with pyridine moieties.
Topics: Apoptosis; Cell Survival; Hep G2 Cells; Humans; Indoles; Isoindoles; Neoplasms, Experimental; Organo | 2016 |
Synthesis and antiproliferative activity of benzophenone tagged pyridine analogues towards activation of caspase activated DNase mediated nuclear fragmentation in Dalton's lymphoma.
Topics: Animals; Benzophenones; Caspases; Cell Nucleus; Cell Proliferation; Deoxyribonucleases; DNA Fragment | 2016 |
[BIOCHEMICAL STUDY OF THE EFFECT OF THE CYTOSTATIC QUARTZ ACTION THROUGH 3 LOW-MOLECULAR PYRIDINE-N-OXIDE COMPOUNDS ON AN ESTABLISHED CELL STRAIN (L929)].
Topics: Antineoplastic Agents; Cytostatic Agents; Neoplasms; Neoplasms, Experimental; Nitrous Oxide; Pyridin | 1964 |